BioXcel Therapeutics
BTAI
BTAI
30 hedge funds and large institutions have $770K invested in BioXcel Therapeutics in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
76% less capital invested
Capital invested by funds: $3.21M → $770K (-$2.44M)
78% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 23
Holders
30
Holding in Top 10
–
Calls
$17K
Puts
$4K
Top Buyers
| 1 | +$276K | |
| 2 | +$50.3K | |
| 3 | +$44.6K | |
| 4 |
BPA
Beacon Pointe Advisors
Newport Beach,
California
|
+$38.3K |
| 5 |
VF
Virtu Financial
New York
|
+$19.8K |
Top Sellers
| 1 | -$1.61M | |
| 2 | -$112K | |
| 3 | -$39.2K | |
| 4 |
Renaissance Technologies
New York
|
-$29.1K |
| 5 |
State Street
Boston,
Massachusetts
|
-$28.8K |
